Life Science & Biotech

Lilly counting on diabetes products to challenge larger rivals

October 8, 2012
Bloomberg News
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
More

IBJ Health Care Power Breakfast - transcript

October 2, 2012
Indianapolis Business Journal convened a panel of experts at its Health Care & Benefits Power Breakfast on Sept. 28 to talk about industry issues including Medicaid, on-site health clinics and narrow networks. Panelists included Robert J. Brody, president and CEO of Franciscan St. Francis Health; Michael N. Heaton, partner, Katz Sapper & Miller; Dr. Gregory N. Larkin, commissioner, Indiana State Department of Health; Vicki F. Perry, president, CEO, Advantage Health Solutions Inc.; Dr. Ram Yeleti, president, Community Physician Network. The following is the unedited transcript of the discussion.
More

Dow Agro awarded $5.3M in patent-infringement case

October 2, 2012
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products from affiliates of Dow AgroSciences violated two of its patents.
More

Vegetable growers, Dow settle dispute over new herbicide

September 11, 2012
J.K. Wall
A coalition of vegetable growers and food producers led by Indiana-based Red Gold Inc. will ease off their opposition to a new herbicide developed by Indianapolis-based Dow AgroSciences LLC.
More

$100M IU neuroscience center set to open

August 24, 2012
Associated Press
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
More

Life sciences firm Hologic closing 200-worker Zionsville facility

August 15, 2012
J.K. Wall
Massachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville, bringing an end to 200 local jobs.
More

Indiana life sciences companies rethink innovationRestricted Content

July 28, 2012
J.K. Wall
Research and development comes under pressure in an age of austerity.
More

Indiana Blood Center tapping new vein of revenueRestricted Content

July 28, 2012
Mason King
Group sees role in cellular therapy as growth area with profit margins higher than core business.
More

Life Sciences Power Breakfast - transcript

July 28, 2012
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation at the July 25 event.
More

Cook Medical shelves Midwest expansion plans

July 27, 2012
J.K. Wall
Life Sciences Cook Yonkman watch videoCook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
More

Dow Agro sales surge to record in second quarter

July 26, 2012
The Indianapolis-based division of Dow Chemical Co. posted record second quarter sales of $1.7 billion, up 12 percent from the year-ago period, due to a small increase in prices and the introduction of new products.
More

Bioanalytical taps accountant for turnaround

July 9, 2012
J.K. Wall
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
More

Life sciences hold up in recession

June 25, 2012
J.K. Wall
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More

Biomet gives ortho industry hope

June 18, 2012
J.K. Wall
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
More

Orthopedic startups attracting big moneyRestricted Content

June 9, 2012
J.K. Wall
The Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more fuel into a fairly stagnant entrepreneurial sector.
More

House swipes at health law with repeal of medical device tax

June 8, 2012
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
More

IU research leads to new genetic test

June 4, 2012
J.K. Wall

It took the identification of 19 different genes for researchers at the Indiana University School of Medicine to develop a test for a rare form of cancer. But their gene-hunting has paid off, as a Texas-based company announced Monday the test is available for doctors to use.

More

U.S. losing drug-research jobs to other countries

May 17, 2012
Bloomberg News
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
More

Indiana slips in life sciences funding

May 14, 2012
J.K. Wall
Indiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies, according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More

Cancer tools help Roche with Alzheimer's drug

May 13, 2012
Bloomberg News
Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.
More

SCHREIBER: Innovation will drive health care industryRestricted Content

May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More

BioCrossroads launches second seed fund

April 30, 2012
J.K. Wall
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
More

Zimmer profit up slightly, meets expectations

April 26, 2012
Associated Press
Indiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit on higher sales in all global regions, particularly the Asia Pacific.
More

Dow Agro sales surge on healthy ag market

April 26, 2012
J.K. Wall
Sales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting season in North America and a buoyant agricultural market.
More

Purdue set to start building life sciences park

April 19, 2012
Associated Press
The $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. This is a big help. Thanks for share it here.

  2. Doug Henning!

  3. These guy were thugs — they grew up in freaking Haughville! Smh, sigh. If the mayor needs/wants "quality" Black Hoosiers who are NOT corrupt, give me a call — I know plenty. Land bank info here - http://www.kubepharm.com/indylandbank/IndyLandBank.html

  4. Magician and illusionist!

  5. The basic idea of nice apartments with parking and retail is a good one, but this design seems overwhelmingly big/tall for Broad Ripple. The size could be disguised a bit with lots of big trees/landscaping, but the complex is too massive to blend in easily. That section of canal between College and Westfield will also need to be upgraded on both sides. Nice apartments facing onto a nice promenade with shade trees/plantings could bring together the canal towpath/Monon recreation, the outdoor seating at existing restaurants, and this project into something that upgrades the whole area. A plan for the whole stretch makes more sense than facing nice new housing onto what looks like a ditch. Is there a plan? Does the public have input? Who pays? The apartment idea seems to be reasonable, but Whole Foods is not a good idea for appropriate retail. Besides the store being physically too big, there are already Fresh Market at 54xCollege and Whole Foods in Nora for fancy groceries. Good Earth and Kroger are within walking distance of the Shell site. There are at least 7 grocery stores within a safe bike ride. Whole Foods would add nothing but traffic congestion. This design is on the right track, but there needs to be more work done to ensure that it blends in with and enhances the existing community. A project that large will set a tone for that whole part of town. It could be a real asset, but only if done right.

ADVERTISEMENT